On August 27, 2025 enGene Holdings Inc. (Nasdaq: ENGN or "enGene"), a clinical-stage, non-viral gene therapy company, reported that management will participate in the following investor conferences in September (Press release, enGene, AUG 27, 2025, View Source [SID1234655538]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Wells Fargo Healthcare Conference
Date: Wednesday, September 3, 2025
Time: 8:45 a.m. ET

H.C. Wainwright 27th Annual Global Investment Conference
Date: Monday, September 8, 2025
Time: 1:30 p.m. ET

Morgan Stanley 23rd Annual Global Healthcare Conference
Date: Wednesday, September 10, 2025
Time: 1:50 p.m. ET

A live webcast of these events can be accessed under the "Investors" section of the enGene website at www.engene.com and will be archived there for 90 days.